BANK OF AMERICA CORP /DE/ - REXAHN PHARMACEUTICALS INC ownership

REXAHN PHARMACEUTICALS INC's ticker is RNN and the CUSIP is 761640101. A total of 31 filers reported holding REXAHN PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of REXAHN PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2016$0
-100.0%
1,822
-92.1%
0.00%
Q2 2016$6,000
+100.0%
22,974
+187.2%
0.00%
Q1 2016$3,000
-91.9%
8,000
-84.0%
0.00%
Q1 2015$37,000
+5.7%
50,0000.0%0.00%
Q4 2014$35,000
-46.2%
50,000
-37.5%
0.00%
Q3 2014$65,000
+14.0%
80,000
+23.1%
0.00%
Q2 2014$57,000
-18.6%
65,0000.0%0.00%
Q1 2014$70,000
+169.2%
65,000
+29.1%
0.00%
Q4 2013$26,000
+13.0%
50,363
+0.7%
0.00%
Q3 2013$23,000
+4.5%
50,0000.0%0.00%
Q2 2013$22,00050,0000.00%
Other shareholders
REXAHN PHARMACEUTICALS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Northeast Financial Consultants Inc 150,000$105,0000.06%
Benin Management CORP 83,000$58,0000.03%
CONDOR CAPITAL MANAGEMENT 121,324$85,0000.02%
First Heartland Consultants, Inc. 30,000$21,0000.01%
FCG ADVISORS, LLC 15,000$11,0000.01%
Advisory Services Network, LLC 22,000$16,0000.01%
Virtu KCG Holdings LLC 346,822$243,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 180,000$126,0000.00%
Moors & Cabot, Inc. 18,000$12,0000.00%
Corbenic Partners LLC 1,600$1,0000.00%
View complete list of REXAHN PHARMACEUTICALS INC shareholders